Skip to main content
$99.08 $0.46 (0.5%)

04:00 PM EDT on 03/30/23

Abbott Laboratories Com Stk NPV (NYSE:ABT)

CAPS Rating: 4 out of 5

Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products.

Current Price $99.08 Mkt Cap $171.4B
Open $99.38 P/E Ratio 22.81
Prev. Close $99.08 Div. (Yield) $2.04 (2.1%)
Daily Range $98.51 - $99.48 Volume 5,199,311
52-Wk Range $93.25 - $124.36 Avg. Daily Vol. 5,170,653

Caps

How do you think NYSE:ABT will perform against the market?

Add Stock to CAPS Watchlist

All Players

2,487 Outperform
96 Underperform
 

All-Star Players

493 Outperform
13 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:ABT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

LocalLegend (98.72)
Submitted January 05, 2013

Spin Off ABBV on the 1/2/13. Score should be corrected to account for Spin Off.

foolmetentimes (69.48)
Submitted January 16, 2009

I wish I had owned this stock last year....

Recent Community Commentary

Read the most recent pitches from players about ABT.

Recs

0
Member Avatar mrbill6 (52.86) Submitted: 10/23/2022 4:36:52 PM : Outperform Start Price: $96.05 NYSE:ABT Score: -4.25

3 Dividend Stocks to Buy Now for a Lifetime of Passive Income
by Cory Renauer, The Motley Fool • October 18, 2022

Recs

0
Member Avatar TMFWordman5150 (48.25) Submitted: 6/8/2022 9:36:00 AM : Outperform Start Price: $114.61 NYSE:ABT Score: -11.10

Abbott has been a leader for years. Concerns over its patent expiration of top selling drug Humira will eventually level out because of its 50 years of consecutive annual dividend increases. Once the pipeline of drugs (Skyrizi, Rinvoq, etc.) catch on more it will boost the stock. Healthcare is a must during any market conditions. Those that have dropped a little more than they should have due to the broader market decline will bounce back stronger.

Recs

0
Member Avatar DZBV216 (< 20) Submitted: 4/21/2022 1:56:24 PM : Outperform Start Price: $123.11 NYSE:ABT Score: -10.92

hnacx add

Leaderboard

Find the members with the highest scoring picks in ABT.

Score Leader

owlcreek

owlcreek (48.26) Score: +415.68

The Score Leader is the player with the highest score across all their picks in ABT.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
TMFMojo 60.70 5/27/2006 Outperform 5Y $14.15 +600.02% +235.76% +364.26 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. GW1000 86.63 6/14/2006 4/11/2021 Outperform 5Y $14.15 +600.24% +251.91% +348.34 0 Comment
forestbin 94.98 11/10/2006 Outperform 5Y $15.11 +555.87% +210.03% +345.83 0 Comment
lucapacioli1492 < 20 11/10/2006 Outperform 3Y $15.16 +553.71% +210.40% +343.32 1 Comment
Brent1966 57.56 11/10/2006 Outperform 1Y $15.19 +552.43% +210.20% +342.22 0 Comment
BANKERTMP 64.65 11/10/2006 Outperform 5Y $15.19 +552.43% +210.20% +342.22 0 Comment
azmagno < 20 11/10/2006 Outperform 1Y $15.22 +550.93% +210.09% +340.85 0 Comment
hoftiezer < 20 11/10/2006 Outperform 5Y $15.24 +550.02% +210.11% +339.90 0 Comment
foolduke 81.75 11/14/2006 Outperform NS $15.32 +546.91% +207.88% +339.03 0 Comment
REMMAKER < 20 11/10/2006 Outperform 5Y $15.32 +546.91% +210.10% +336.82 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ABT.